N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine(CAS号:2030-63-9)
氯苯吩嗪
基本信息
![N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine](/structs/203/2030-63-9-f3d9.webp)
CAS号
2030-63-9
分子式
C27H22Cl2N4
分子量
473.41 g/mol
Quick Actions
基本物理性质
熔点
210-213°C
沸点
616.26°C (rough estimate)
闪点
296.7°C
折射率
1.6300 (estimate)
安全信息
查看安全信息危险说明
H315; H319; H335
毒性
LD50 orally in mice, rats, and guinea pigs: >4 g/kg (Stenger)
同义词与参考文献
英文
- Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-
- B663
- SR-05000001807-1
- 2-Phenazinamine,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #
- N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-phenazin-2-amine
- DTXSID7022839
- GTPL9184
- SCHEMBL26757
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- HY-B1046
- C2866
- NCGC00016600-02
- CLOFAZIMINE [ORANGE BOOK]
- B 663 (VAN)
- HMS3370N05
- AMY22515
- HMS3713K13
- Lamprene (TN)
- CLOFAZIMINE [USAN]
- J-013203
- G-30320
- AKOS026749881
- BRD-K56614220-001-10-9
- B. 663
- NC00409
- Pharmakon1600-01505974
- SMR000058704
- Phenazine, 2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
- Chlofazimine
- C06915
- cid_2794
- (3E)-N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
- DB00845
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
- NS00011720
- N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
- 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
- 2030-63-9
- CLOFAZIMINE [VANDF]
- CHEMBL1083384
- CLOFAZIMINE [USP-RS]
- Tox21_110516
- HMS3652A16
- HMS2052B05
- (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
- Prestwick0_000376
- SCHEMBL26758
- Clofazimine, European Pharmacopoeia (EP) Reference Standard
- 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
- NSC-141046
- MLS006010789
- B 663, pharmaceutical
- Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard
- HMS2096K13
- CLOFAZIMINE [EP MONOGRAPH]
- HMS3394B05
- EINECS 217-980-2
- KS-1412
- CLOFAZIMINE [INN]
- MLS000028617
- MMV687800
- NCGC00016600-07
- NCGC00016600-09
- SR-05000001807-2
- MLS001424318
- Clofazimine [USAN:USP:INN:BAN]
- SR-01000000259-6
- N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine
- 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
- CLOFAZIMINE [USP IMPURITY]
- 2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-
- Prestwick2_000376
- CCG-269477
- BCP07792
- CLOFAZIMINE [JAN]
- NSC-759283
- SMR004701474
- Clofazimine 100 microg/mL in Acetonitrile
- Phenazine,10-dihydro-2-(isopropylimino)-
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
- 2458811-14-6
- B-663
- N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
- BIDD:PXR0147
- Phenazine,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-
- Clofaziminum
- (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine
- Prestwick3_000376
- 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
- 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
- NCGC00179529-01
- D959AE5USF
- Clofazimina
- CPD000058704
- UNII-D959AE5USF
- SPBio_002452
- BSPBio_000531
- N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-2-phenazinamine
- NCGC00016600-08
- Q418611
- G 30320
- KUC109573N
- SR-05000001807
- HMS2093J10
- KSC-27-052A
- 2-Phenazinamine,N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- COLFAZIMINE [VANDF]
- FT-0657414
- NCGC00016600-04
- D00278
- BDBM50378783
- NSC759283
- Clofazimina [INN-Spanish]
- (3E)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine
- s4107
- (E)-N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
- B 663
- Prestwick_685
- EN300-267815
- AKOS015896438
- Lamprene
- SW196840-4
- CLOFAZIMINE [WHO-IP]
- BPBio1_000585
- BDBM50318909
- 4-25-00-03033 (Beilstein Handbook Reference)
- EN300-21680301
- SR-01000000259
- CAS-2030-63-9
- CLOFAZIMINE [MI]
- Clofazimine, United States Pharmacopeia (USP) Reference Standard
- SBI-0206865.P001
- Lampren
- Riminophenazine
- HMS1569K13
- CLOFAZIMINE [WHO-DD]
- WDQPAMHFFCXSNU-KRUMMXJUSA-N
- SMP2_000339
- N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
- Prestwick1_000376
- CCG-101159
- NSC 141046
- CLOFAZIMINUM [WHO-IP LATIN]
- Clofaziminum [INN-Latin]
- Clofazimine (JAN/USP/INN)
- 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-
- CS-4567
- CLOFAZIMINE [USP MONOGRAPH]
- DTXCID302839
- A814428
- clofazimine
- HMS2231B04
- Z2037279473
- 2-p-Chloranilino-5-p-chlorphenyl-3,5-dihydro-3-isopropylimino-phenazin
- Colfazimine
- SCHEMBL5663361
- NSC141046
- B 663 (Pharmaceutical)
- NCGC00016600-03
- NCGC00016600-01
- MFCD00056793
- BRN 0060420
- N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine
- CHEMBL1292
- CHEBI:3749
- CLOFAZIMINE [MART.]
- NCGC00016600-05
- Clofazimine
- Clofazimine-d7
- 2-(4-Chlor-anilino)-5-(4-chlor-phenyl)-3-isopropylamino-phenazinium-betain
- 2-(4-chloro-anilino)-5-(4-chloro-phenyl)-3-isopropylamino-phenazinium-betaine
- Clo
- Clofazimine (N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
中文
- 氯苯吩嗪
- N,5-二(4-氯苯基)-3,5-二氢-3-(异丙亚氨基)吩嗪-2-胺
- 氯法齐明
- (3-羧丙基)三甲基氯化铵
- Clofazimine 氯法齐明
- 氯苯吩嗪 USP标准品
- 氯苯吩嗪标准品
- 氯法齐明 EP标准品
- 氯法齐明-D7
- 氯法齐明标准品
- 氯法齐明系统适用性 EP标准品
- 氯法齐明杂质
- 2-对氯苯胺基-5-对氯苯基-3,5-二氢-3-异丙亚氨基吩嗪
- N,5-二(4-氯苯基)-3,5-二氢-3-(异丙基亚胺)吩嗪-2-胺
- 螺旋霉素
MDL_Number
MFCD00056793
CAS号
2030-63-9
Customs_Code
35040000
Merck_Index
2373
供应商信息
供应商名称 | 会员等级 | 认证状态 | 主要类别 | 最小订购量 | 操作 |
---|---|---|---|---|---|
相关文献
A hollow neuronal carbon skeleton with ultrahigh pyridinic N content as a self-supporting potassium-ion battery anode
Yongwen Sun, Ya Zhang, Zheng Xing, Denghu Wei, Quanchao Zhuang
DOI: 10.1039/C9SE00889F
Catalogue of self-targeting nano-medical inventions to accelerate clinical trials
Samar A. Alsudir
DOI: 10.1039/D1BM00235J
Synthesis of aviation fuel from bio-derived isophorone
Courtney Ford Ryan, Cameron M. Moore, Juan H. Leal, Troy A. Semelsberger, Jenny K. Banh, Junqing Zhu, Charles S. McEnally, Lisa D. Pfefferle, Andrew D. Sutton
DOI: 10.1039/C9SE01014A
Increasing efficiency of perovskite solar cells using low concentrating photovoltaic systems
Hasan Baig, Hiroyuki Kanda, Abdullah M. Asiri, Mohammad Khaja Nazeeruddin, Tapas Mallick
DOI: 10.1039/C9SE00550A
Redox responsive Pluronic micelle mediated delivery of functional siRNA: a modular nano-assembly for targeted delivery
Sandeep Kadekar, Ganesh N. Nawale, Vadim Le Joncour, Pirjo Laakkonen, Jöns Hilborn, Oommen P. Varghese, Oommen P. Oommen
DOI: 10.1039/D1BM00428J
Biomaterials Science Emerging Investigators 2021
Maria E. Southall
DOI: 10.1039/D1BM90053F
Engineering nanoporous organic frameworks to stabilize naked Au clusters: a charge modulation approach
Chengcheng Tian, Xiang Zhu, Huize Wang, Hai Wang, Carter W. Abney, Ning Zhang
DOI: 10.1039/C8CC02966K
CaMoO4 nanosheet arrays for efficient and durable water oxidation electrocatalysis under alkaline conditions
Ying Gou, Qin Liu, Xifeng Shi, Abdullah M. Asiri, Jianming Hu, Xuping Sun
DOI: 10.1039/C8CC02092B